Compounds > vancomycin
Page last updated: 2024-08-21

vancomycin and mdl 62873

vancomycin has been researched along with mdl 62873 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biavasco, F; Lupidi, R; Varaldo, PE1
Bartoloni, A; Colao, MG; Dei, R; Giganti, E; Orsi, A; Parenti, F1
Biavasco, F; Manso, E; Varaldo, PE1
Goldstein, FW; Jones, RN; Zhou, XY1
Capodicasa, E; De Bellis, F; Del Favero, A; Marconi, P; Rosati, E; Sbaraglia, G; Scaringi, L1
Ena, J; Houston, A; Jones, RN; Wenzel, RP1

Other Studies

6 other study(ies) available for vancomycin and mdl 62873

ArticleYear
In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:2

    Topics: Actinomycetales; Anti-Bacterial Agents; Bacteria, Anaerobic; Drug Resistance, Microbial; Glycopeptides; Gram-Positive Bacteria; Listeria monocytogenes; Microbial Sensitivity Tests; Peptides, Cyclic; Ristocetin; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin

1992
In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 26, Issue:5

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Daptomycin; Depsipeptides; Drug Resistance, Microbial; Glycopeptides; Gram-Positive Bacteria; Methicillin Resistance; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Rifamycins; Ristocetin; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin

1990
In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:1

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Depsipeptides; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Glycopeptides; Humans; Microbial Sensitivity Tests; Peptides, Cyclic; Ristocetin; Teicoplanin; Vancomycin

1991
Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United States.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:3

    Topics: Anti-Bacterial Agents; Bacteroides fragilis; France; Glycopeptides; Microbial Sensitivity Tests; Ristocetin; Staphylococcus; Teicoplanin; United States; Vancomycin

1991
In-vitro effects of teicoplanin, teicoplanin derivative MDL 62211 and vancomycin on human polymorphonuclear cell function.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Adhesion; Chemotaxis; Glycopeptides; Humans; Neutrophils; Phagocytosis; Ristocetin; Teicoplanin; Vancomycin

1991
Trends in gram-positive bloodstream organism resistance: a seven-year audit of five glycopeptides and other drugs at a large university hospital.
    Journal of chemotherapy (Florence, Italy), 1993, Volume: 5, Issue:1

    Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Hospitals, University; Humans; Lactams; Microbial Sensitivity Tests; Ristocetin; Staphylococcus; Time Factors; Vancomycin

1993